Federal Autism Panel’s Push for "Profound Autism" Label Sparks Controversy Amidst Procedural Concerns
A significant shift within a key federal autism advisory panel, orchestrated by U.S. Secretary of Health and Human Services Robert…
controversy
FDA Withdraws Approval of Wellcovorin, Branded Leucovorin, Amidst Autism Treatment Controversy
The U.S. Food and Drug Administration (FDA) has formally withdrawn its approval for Wellcovorin, the branded version of leucovorin, marking…
